Navigation Links
Decision Resources Group Acquires Relay Technology Management
Date:1/7/2014

BURLINGTON, Mass. and CAMBRIDGE, Mass., Jan. 7, 2014 /PRNewswire/ -- Piramal Enterprises' Information Management Subsidiary, Decision Resources Group, one of the world's leading research and advisory firms focusing on high-value healthcare insights and analytics, announced today that it acquired Relay Technology Management, a data analytics company focused on the life-sciences industry. The acquisition of Cambridge, Mass.-based Relay by Burlington, Mass.-based Decision Resources Group is a significant strategic step in Decision Resources Group's effort to supply its clients with premier data analytics through delivery systems that most fit their needs.

Jim Lang, CEO of Decision Resources Group said, "This important acquisition brings us three things, 1) exciting products for early stage pipeline analysis, drug target evaluation, and KOL identification, 2) a world class data and analytics leadership team, and 3) proprietary natural language processing technology, healthcare ontology, and scalable data and insight visualization platform to allow us to introduce new products and services much more quickly to our clients and to enhance our current high-value offerings."

Relay's concentration in the life-sciences industry means they are familiar with the various disparate databases and information sources that Decision Resources Group's pharmaceutical and medtech clients work with on a regular basis. They offer a way to organize and synthesize these data sets to service a multitude of organizational users.

"With Relay's ability to make sense of disparate structured and unstructured data, we can then layer on the 'so-what' insights from our premier analysts to add value to those data views – this will allow our clients to have a level of intelligence that is second-to-none in the industry," continued Mr. Lang.

"We look forward to applying our next-generation, interactive data analytics platform to Decision Resources Group's strong multidimensional offering known for top-level analysis and insight," said Brigham Hyde, CEO of Relay Technology Management. "Together, Decision Resources Group and Relay will deliver the type of data-driven solutions and predictive analytics that is critical to the current competitive environment of today's biopharma and device organizations."

Relay will move to Decision Resources Group's corporate office location in Burlington, Mass.

About Relay Technology Management
Relay Technology Management is a life sciences business intelligence and analytical software provider founded in 2008 with one core belief: that enabling data-driven decision-making via objective, standard asset valuation and trend analytics will led to increased efficiency in drug and device development. Data-driven decision-making is the key to delivering novel, cost effective, and efficacious care to patients worldwide. For more information on Relay, please visit: www.relaytm.com

About Decision Resources Group
Decision Resources, Inc. is a world leader in high-value data, analytics and advisory services designed to help clients shape strategy, allocate resources and master their chosen markets. For more information, please visit www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or
registered trademarks of their respective holders.

For more information, contact:

Elizabeth Marshall
Decision Resources Group
781-993-2563
emarshall@dresourcesgroup.com


'/>"/>
SOURCE Decision Resources Group
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Genomic Health Presents Results From First Clinical Decision Making Study of Oncotype DX® Colon Cancer at the 2012 Gastrointestinal Cancers Symposium
2. Sequenom Addresses Preliminary Injunction Decision, Reaffirms Defense of Patent
3. Laboratory Decision Makers Cautiously Optimistic about Funding Conditions, Finds Frost & Sullivan
4. Neural implant recovers ability to make decisions
5. QIAGEN and Bayer HealthCare Partner to Develop Companion Diagnostics to Guide Treatment Decisions for Targeted Cancer Therapies
6. Country and Site Selection: Optimizing Protocol Planning Decisions by Leveraging Data Through Custom Algorithms, New Webinar Hosted by Xtalks
7. Butamax Announces Immediate Appeal of Court Decisions on Claim Construction and Summary Judgment
8. Health Decisions CEO Michael Rosenberg Named a Business Leader Top Entrepreneur for 2013
9. Advancing Preclinical Predictions, Making Faster Clinical Decisions with Cancer Models and Preclinical Imaging - World Pharma Congress this June in Philadelphia
10. Computational Analysis in Clinical and Preclinical Decision-Making, new webinar hosted by Xtalks
11. ChemAxon Major Software Release brings New Desktop, Web and Visualization Applications to Power Chemistry Decision Making
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report ... detail how a patient who developed lymphedema after being treated for breast cancer benefitted ... change the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... quality, regulatory and technical consulting, provides a free webinar on Performing ... July 13, 2016 at 12pm CT at no charge. , Incomplete investigations are ...
(Date:6/23/2016)... ReportsnReports.com adds 2016 global ... pharmaceuticals section with historic and forecast data along ... Complete report on the Cell Culture ... companies and supported with 261 tables and figures ... The Global Cell Culture Media Industry ...
Breaking Biology Technology:
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
Breaking Biology News(10 mins):